OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/12/2026
Back to search
Official data from USPTO
PREDIDIAB PRÉDIRE POUR PRÉVENIR
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
08/12/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
01/17/2025
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
08/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
34
Owner location
FR
Examiner
FLETCHER, TRACY L
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of three vertical orange oval figures, with the left figure having an orange circle above it, the central figure having a green circle above it and the right figure have a green and orange circle above it, all appearing above the green wording "PREDIDIAB PRÉDIRE POUR PRÉVENIR; the color white represents transparent areas and is not part of the mark.
Holders and representatives
Holders
PrédiDiab
Representatives
Andrew D. Bochner Bochner PLLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for the treatment of diabetes; pharmaceutical and veterinary preparationsmedicinal preparations for regulating blood sugar and improving glucose metabolismdietary supplementsdietetic food adapted for medical usesanitary preparations for medical purposes; sanitary products for medicine being sanitary sterilizing preparations; dietetic foods and beverages adapted for medical use; chemical reagents for medical and pharmaceutical use; vaccines; food for babies; medical plastersgauze for dressings; disinfectants; vitaminsvitamin-based preparations being dietary supplements; natural dietetic foods based on medicinal plants for medical and veterinary use; nutritionally fortified beverages and foods for medicinal use; additives in the nature of dietary supplements for humans and for animals for medicinal use; mineral food supplements for medicinal use; nutritional supplementsplant-based dietary supplements for medicinal use; food supplements containing proteinscarbohydrateslipidsfibersmicronutrientsfor medical use; plant extracts other than essential oils for medicinal use; preparations for making dietetic and medicated beveragespowdered nutritional supplement drink mix and concentrate; medicinal preparationspreparations for the treatment of diabetes; chemical preparations for medicinal use being chemical reagents for medical purposes; substances for medicinal use being medicinal drinks; medicated candy and confectionery for medicinal use; medicated pharmacological preparations for skin care; medical diagnostic products being diagnostic preparations for medical purposes; kit for detecting a risk of predisposition to diabetes being diagnostic kits consisting primarily of monoclonal antibodiesbuffersreagents for use in disease testing; chemical preparations for the diagnosis of diabetes being diagnostic preparations for medical purposes; pharmaceutical preparations for the prevention and treatment of diabetes
Class 42
Scientific researchscientific investigations for medical purposes; technological consulting services for digital transformation new product development; industrial design; medical and pharmacological research services; development of pharmaceutical products for others; carrying out evaluations of pharmaceutical products being product quality evaluation services; carrying out testing on pharmaceutical products being product quality testing services; laboratory research services concerning pharmaceuticals; computer programming in the medical field; management of data for medical use being electronic data storage of medical data; information and advisory services relating to the aforesaid services; providing scientific research consultation and consultancy pertaining to pharmacology
Publications
History of USPTO decisions and trademark events.
24 publications found
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
08/12/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
GPNX
NOTIFICATION PROCESSED BY IB
03/05/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/18/2026
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
02/17/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/10/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/05/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/05/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/05/2026
RFNT
REFUSAL PROCESSED BY IB
08/29/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/13/2025
RFRR
REFUSAL PROCESSED BY MPU
08/12/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/28/2025
CNRT
NON-FINAL ACTION WRITTEN
06/27/2025
DOCK
ASSIGNED TO EXAMINER
06/26/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/16/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/16/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
03/13/2025
Continuous trademark protection
Get notified about every new filing that threatens PREDIDIAB PRÉDIRE POUR PRÉVENIR or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.